Cargando…
Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?
Autores principales: | Van Gool, Stefaan W., Makalowski, Jennifer, Kampers, Linde F. C., Van de Vliet, Peter, Sprenger, Tobias, Schirrmacher, Volker, Stücker, Wilfried |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493805/ https://www.ncbi.nlm.nih.gov/pubmed/37701100 http://dx.doi.org/10.21037/tcr-23-603 |
Ejemplares similares
-
The Application of Evidence-Based Medicine in Individualized Medicine
por: Van de Vliet, Peter, et al.
Publicado: (2023) -
IMMU-02. CMV-EXPANDED T-CELLS IN GLIOBLASTOMA PATIENTS: TRANSLATIONAL RESEARCH
por: Kampers, Linde F C, et al.
Publicado: (2023) -
Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience
por: Van Gool, Stefaan W., et al.
Publicado: (2023) -
Neurological research and practice: the first milestone has been reached
por: Hacke, Werner
Publicado: (2021) -
Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients
por: Van Gool, Stefaan W., et al.
Publicado: (2022)